Novavax Inc. plans to sell up to $75 million of its common shares from time to time in at-the-market offering.
B. Riley FBR Inc. is acting as the sales agent for the offering.
Discover more about S&P Global’s offerings
Novavax plans to sell $75M of common stock
Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion
Global M&A by the Numbers: Q2 2022
Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms
Infographic 2022 Top Tech Trends Shaping Corporations
Novavax Inc. plans to sell up to $75 million of its common shares from time to time in at-the-market offering.
B. Riley FBR Inc. is acting as the sales agent for the offering.